Teva
Teva collaborates on skin disease treatment, releases targets
Under the agreement with Royalty Pharma, the companies will jointly develop the anti-IL-15 antibody, TEV-'408, which is in a phase 1b trial for the treatment of vitiligo
Teva seeks startups to help solve global pharmaceutical challenges
Placing the focus on the therapist
Does a common heart attack pill help everyone? Studies disagree
Israeli drug-maker Teva to recall certain blood pressure medicine in U.S.
Teva has not received any reports of adverse events signaling a potential link or exposure to valsartan, the health regulator said.
Teva continues to wobble as rival drug receives FDA approval
Only two weeks ago, Teva received approval for its newly-developed migraine drug known as Ajovy, raising hopes of improved financial fortunes.
U.S. approval of Teva drug could help reverse company’s migraines
The newly-approved preventive migraine drug could bring in as much as $500 million in sales annually.
Will migraine drug approval make Teva a success again?
The U.S. Food and Drug Administration approved a new migraine treatment Teva created, which has potentially 39 million Americans buyers.
Teva jumps on FDA approval for generic EpiPen
FDA approves Teva’s generic of Mylan’s EpiPen
"...Patients living with severe allergies should have a lower-cost option."
A tribute to companies whose products have become Israeli icons worldwide
ZIM CEO Eli Glickman pays homage to the CEOs of Teva Israel, Mehadrin, Keter Plastic, and other prominent Israeli companies
Media Comment: Media-assisted legal irresponsibility
We need remind ourselves that all instruments of power, governmental and non-governmental, are never totally free of weaknesses.
Warren Buffett wagers big on Teva, and on Israel
The purchase initially sent share prices soaring by 12 percent.
Beit Berl College to re-train former Teva workers as chemistry teachers
The Education Ministry will cover the cost of tuition loans that will convert into grants after two years of teaching in the field.
